← FDA Drug Approvals (Drugs@FDA)
DOXORUBICIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HISUN PHARM HANGZHOU · Approved 2019-05-13
Drug application
- FDA Application #
ANDA206062- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXORUBICIN HYDROCHLORIDE
- Generic name
- Doxorubicin Hydrochloride
- Active ingredients
- DOXORUBICIN HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- HISUN PHARM HANGZHOU
- First approval
- 2019-05-13
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown